BioPharma APAC

Closer Study of Major Autism Gene Suggests Possible Treatment Approach

Research led by a scientist at Cincinnati Children's who primarily studies brain tumors may open doors for improved treatment of autism. Autism spec...

September 26, 2022 | News

Persistent Loss of Smell Due to Covid-19 Closely Connected to Long-Lasting Cognitive Problems

Also, ICU Stay May Double Risk of Dementia in Older Adults SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- New insights into factors that may...

August 01, 2022 | News

FDA Clears DyAnsys Neurostimulation Device First Relief to treat Diabetic Neuropathic Pain

The wearable device placed on the ear administers continuous pulses of a low-level electrical current over several days. With the FDA clearance of First R...

July 18, 2022 | News

IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program

This application will help clinicians to better serve patients with neurological disorders and provide treatments in the functional neuroscience domain. Th...

June 28, 2022 | News

COVID-19 causes increased risk of developing neurodegenerative disorders

Covid-19-positive outpatients have a higher risk of neurodegenerative disorders compared to people who tested negative for the virus, a new study presented...

June 27, 2022 | News

RAD adds brain tumor technology to portfolio

Sublicensing of promising imaging & therapeutic radiopharmaceutical from leading US university, Case Western Reserve University (CWRU),&nbs...

June 13, 2022 | News

The 3rd BIO International Convention 2022 is Approaching

Neurophth Therapeutics is a leading clinical-stage gene therapy company with robust ophthalmic pipeline. With subsidiaries in China and USA,...

June 09, 2022 | News

NeuroAiD has shown favourable outcome in patients suffering from spinal cord injuries

NeuroAiD was safe as add-on treatment in patients with severe SCI. One third of patients improved on ASIA Impairment Scale (AIS) grading with ...

June 07, 2022 | News

Aruna Bio Advances Therapeutic Development for Traumatic Brain Injury

"The successful completion of the proposed study is intended to provide key information pertaining to AB126™ dosage, and therapeutic effects on T...

June 01, 2022 | News

Changes in brain's visual areas in infancy may precede autism diagnosis

WHAT:Infants who were diagnosed with autism spectrum disorder (ASD) at 24 months old had differences in the visual processing areas of the brain that were ...

May 30, 2022 | News

Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion

The acquisition is one of the largest cross-border transactions in the medical device industry globally in recent years and is driven by strong growth oppo...

April 22, 2022 | News

TauRx's late-stage clinical trial reaches new milestone

TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last patient has completed treatment in t...

April 14, 2022 | News

NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today announced tha...

March 22, 2022 | News

Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals

These deuterated compounds represent next-generation therapeutics with applications across several different psychiatric and neurological conditions. Terra...

March 13, 2022 | News

Stay Connected